Literature DB >> 8434390

Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. V. Dependence of CD4+ suppressor cells on the presence of alloantigen and cytokines, including interleukin 2.

N W Pearce1, A Spinelli, K E Gurley, B M Hall.   

Abstract

CD4+ cells from CsA-treated DA rats with long-surviving PVG heart allografts specifically suppress the capacity of naive CD4+ cells to restore allograft rejection in irradiated DA rats, but have normal donor-specific alloreactivity in MLC. CD4+ suppressor cells from CsA-treated DA rats cultured for 3 days against either PVG or DA spleen cells lost the capacity to transfer suppression into irradiated DA rats grafted with PVG hearts and regained the ability to mediate rejection. However, these cells retained suppressor function when stimulated with donor-specific alloantigen in media supplemented with 20% Con A supernatant. CD4+ cells from CsA-treated rats cultured against either third-party stimulator cells or syngeneic cells expressing anti-PVG idiotype in media supplemented with Con A supernatant failed to maintain suppressor cell function. CD4+ cells from CsA-treated rats cultured in media supplemented with Con A supernatant alone also failed to maintain suppressor function. Suppressor cell function in culture was not maintained by rIL-2. mAb to the IL-2 receptor alpha chain (CD25) prevented the maintenance of suppressor cell function in media supplemented with Con A supernatant. Con A supernatant is rich in IFN-gamma, but addition of an anti-IFN-gamma mAb to the culture did not affect the maintenance of suppressor cells. These studies demonstrate that the CD4+ suppressor cell from CsA-treated rats with long-surviving grafts is short-lived; its survival is dependent upon contact with specific alloantigens and cytokines, one of which is IL-2. In the absence of cytokines and/or specific alloantigen, the CD4+ cells regain the capacity to initiate graft rejection in irradiated rats, suggesting that within the CD4+ subpopulation there is a fragile balance between cells with the capacity to suppress and effect rejection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8434390     DOI: 10.1097/00007890-199302000-00027

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  10 in total

Review 1.  T Cells: Soldiers and Spies--The Surveillance and Control of Effector T Cells by Regulatory T Cells.

Authors:  Bruce M Hall
Journal:  Clin J Am Soc Nephrol       Date:  2015-04-15       Impact factor: 8.237

2.  Immune parameters of mice bearing human head and neck cancer.

Authors:  A Taitz; G Petruzzelli; A S Pak; M A Wright; J P Matthews; W F Raslan; Y Lozano; M R Young
Journal:  Cancer Immunol Immunother       Date:  1995-05       Impact factor: 6.968

3.  Interleukin-12 (IL-12p70) Promotes Induction of Highly Potent Th1-Like CD4(+)CD25(+) T Regulatory Cells That Inhibit Allograft Rejection in Unmodified Recipients.

Authors:  Nirupama Darshan Verma; Bruce Milne Hall; Karren Michelle Plain; Catherine M Robinson; Rochelle Boyd; Giang T Tran; Chuanmin Wang; G Alex Bishop; Suzanne J Hodgkinson
Journal:  Front Immunol       Date:  2014-05-09       Impact factor: 7.561

4.  Changes in Reactivity In Vitro of CD4+CD25+ and CD4+CD25- T Cell Subsets in Transplant Tolerance.

Authors:  Bruce M Hall; Catherine M Robinson; Karren M Plain; Nirupama D Verma; Giang T Tran; Masaru Nomura; Nicole Carter; Rochelle Boyd; Suzanne J Hodgkinson
Journal:  Front Immunol       Date:  2017-08-22       Impact factor: 7.561

5.  Interleukin-5 Mediates Parasite-Induced Protection against Experimental Autoimmune Encephalomyelitis: Association with Induction of Antigen-Specific CD4+CD25+ T Regulatory Cells.

Authors:  Giang T Tran; Paul L Wilcox; Lindsay A Dent; Catherine M Robinson; Nicole Carter; Nirupama D Verma; Bruce M Hall; Suzanne J Hodgkinson
Journal:  Front Immunol       Date:  2017-11-01       Impact factor: 7.561

6.  Alloactivation of Naïve CD4+CD8-CD25+T Regulatory Cells: Expression of CD8α Identifies Potent Suppressor Cells That Can Promote Transplant Tolerance Induction.

Authors:  Nirupama D Verma; Catherine M Robinson; Nicole Carter; Paul Wilcox; Giang T Tran; Chaunmin Wang; Alexandra Sharland; Masaru Nomura; Karren M Plain; G Alexander Bishop; Suzanne J Hodgkinson; Bruce M Hall
Journal:  Front Immunol       Date:  2019-10-14       Impact factor: 7.561

7.  Interleukin-5 (IL-5) Therapy Prevents Allograft Rejection by Promoting CD4+CD25+ Ts2 Regulatory Cells That Are Antigen-Specific and Express IL-5 Receptor.

Authors:  Bruce M Hall; Rachael M Hall; Giang T Tran; Catherine M Robinson; Paul L Wilcox; Prateek K Rakesh; Chuanmin Wang; Alexandra F Sharland; Nirupama D Verma; Suzanne J Hodgkinson
Journal:  Front Immunol       Date:  2021-11-29       Impact factor: 7.561

Review 8.  Transplant Tolerance, Not Only Clonal Deletion.

Authors:  Bruce M Hall; Nirupama D Verma; Giang T Tran; Suzanne J Hodgkinson
Journal:  Front Immunol       Date:  2022-04-21       Impact factor: 8.786

9.  Editorial: Characterisation, functions and roles of antigen-specific regulatory T cells in health and disease.

Authors:  Giang T Tran; Nirupama D Verma; Lesley M Smyth; Bruce M Hall
Journal:  Front Immunol       Date:  2022-09-27       Impact factor: 8.786

10.  Do Natural T Regulatory Cells become Activated to Antigen Specific T Regulatory Cells in Transplantation and in Autoimmunity?

Authors:  Bruce M Hall; Giang T Tran; Nirupama D Verma; Karren M Plain; Catherine M Robinson; Masaru Nomura; Suzanne J Hodgkinson
Journal:  Front Immunol       Date:  2013-08-02       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.